About Airway Therapeutics, Inc.
Airway Therapeutics is a clinical-stage biopharmaceutical company developing immune-modulating therapies for respiratory, inflammatory, and infectious diseases. Their lead candidate, zelpultide alfa, is a first-in-class recombinant protein designed to reduce inflammation and enhance infection clearance.
Is this your company?
Claim Airway Therapeutics, Inc. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim Airway Therapeutics, Inc. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.